From: The impact of native Fallot anatomy on future therapeutic requirements and outcomes at follow-up
Group 1 (65) | Group 2 (108) | Group 3 (66) | P | |
---|---|---|---|---|
Gender male n (%) | 50 (77) | 58 (54) | 39 (59) | 0.009 |
Previous BT shunt n (%) | 8 (12) | 8 (7.4) | 21 (31.8) | 0.001 |
PDA stent | 1 | |||
RVOT stent | 1 | |||
Age at complete repair (years) | 0.66 (0.48–0.92) | 0.67 (0.55–0.92) | 0.7 (0.52–1) | 0.78 |
Type of repair n (%) | < 0.0001 | |||
TAP | 4 (6.2) | 98 (91) | 62 (94) | |
With PAs enlargement | 0 | 2 | 44 | |
Without PAs enlargement | 4 | 96 | 18 | |
Infundibular patch | 26 (40) | 10 (9.4) | 3 (4.5) | |
With PAs enlargement | 1 | 0 | 2 | |
Without PAs enlargement | 25 | 10 | 1 | |
RVOT muscle resection ± PV commissurotomy | 35 (53.8) | 8 (7.5) | 3 (4.5) |